Video Series

Amy Nguyen Howell, MD, MBA, highlights the importance of data collection, analysis, and the new ICD-10-CMZ codes in understanding and resolving health disparities in diabetic macular edema patient care.

Experts discuss strategies for integrating Lp(a) testing into clinical practice across organizations, leveraging new therapies, education, and quality measures for improved patient care.

Experts discuss the integration of Lp(a) testing into cardiovascular risk assessment, and refining preventive strategies and statin use in specific groups.

The panelists provide their final takeaways from the discussion surrounding treatment of MDS.

Potential issues associated with insurance coverage and ways to navigate these challenges are discussed by medical experts.

Experts examine the economic burdens on the health care system, payers, and patients, based on associated costs with dry eye disease.

Panelists underscore the importance of patient education in improving treatment adherence.

Experts explore the efficacy and safety profiles of elacestrant, an oral selective estrogen receptor degrader (SERD), and other options for endocrine therapy. The panelists also discuss clinical trial insights, progression-free survival rates, and tolerability, highlighting outcomes and advances in metastatic breast cancer treatment.

Key opinion leaders emphasize the role of coordinated care between dermatologists and oncologists in monitoring and managing adverse events related to immunotherapy in CSCC and BCC.

Elizabeth Spencer, MD, shares experiences as a caregiver to an adult with eosinophilic esophagitis (EoE), discussing challenges with therapy and insurance, and shedding light on how these experiences also might impact pediatric caregivers.

Elizabeth Spencer, MD, explains how a multidisciplinary team and open communication assist in implementing tailored treatment plans for children with eosinophilic esophagitis (EoE) and offers advice for caregivers of children who are newly diagnosed.

The panelists highlight key takeaways for payors involved in MDS treatment.

Experts discuss how collaborative care drives optimal MDS treatment.

Elizabeth Spencer, MD, explains the role of esophageal dilation in treatment of eosinophilic esophagitis (EoE), highlighting the importance of shared decision-making.

Elizabeth Spencer, MD, discusses the role of proton pump inhibitors (PPIs) in treatment of eosinophilic esophagitis (EoE) in pediatric patients.

Key questions to ask patients during diagnosis of Demodex blepharitis to identify signs and symptoms of the condition are covered by Dr. Yeu.

Michael D. Shapiro, DO, and Jaime Murillo, MD, discuss the implications of high Lp(a) levels in the US population, racial disparities, and tailored interventions for high-risk groups.

Michael D. Shapiro, DO, and Erin D. Michos, MD, MHS, discuss the disproportionately high Lp(a) levels seen across different demographic groups, and the need for increased screening and treatment to mitigate the risk of cardiovascular disease.

Amy Nguyen Howell, MD, MBA, emphasizes ophthalmologists' crucial role in reducing diabetic macular edema (DME) health disparities.

Trajectory of patient outcomes for those diagnosed with bronchiectasis is explored by Dr Metersky.

A panel of medical experts discuss the shift from intervention to prevention in the management of dry eye disease, as well as perspectives on resource allocation.

Experts provide a perspective on disparities in accessibility and outcomes based on the current socioeconomic landscape in health care.

Medical experts discuss unmet needs surrounding treatment of multiple myeloma.

Experts discuss evolving strategies in ER+/HER2– metastatic breast cancer treatment, combining endocrine and targeted therapies, and leveraging specific mutations for optimal patient outcomes.

Key opinion leaders open a discussion surrounding CLL and SLL, and describing unique characteristics of each disease state.

Richard Adler, MD, FACS, Assistant Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins Institute, and Director of Ophthalmology Services at Belcara Health, discusses the critical unmet needs in Dry Eye Disease (DED) therapies and explores the potential impact of new agents in addressing these challenges.

A panel of experts explore desmoid tumor clinical characteristics, heterogeneity, and diagnostic complexities for optimal treatment strategies.